Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:14624657rdf:typepubmed:Citationlld:pubmed
pubmed-article:14624657lifeskim:mentionsumls-concept:C0019682lld:lifeskim
pubmed-article:14624657lifeskim:mentionsumls-concept:C0019699lld:lifeskim
pubmed-article:14624657lifeskim:mentionsumls-concept:C0025517lld:lifeskim
pubmed-article:14624657lifeskim:mentionsumls-concept:C0332281lld:lifeskim
pubmed-article:14624657lifeskim:mentionsumls-concept:C1963724lld:lifeskim
pubmed-article:14624657pubmed:issue11lld:pubmed
pubmed-article:14624657pubmed:dateCreated2003-11-19lld:pubmed
pubmed-article:14624657pubmed:abstractTextIn the last few years, recently developed antirretroviral treatment has allowed a dramatic improvement in the prognosis of HIV disease. As a result, other medical problems are taking increasing relevance in the follow up of the patients infected by such virus. In this article, metabolic disorders associated with HIV, as well as those provoked by antiretroviral therapy, are comprehensively reviewed.lld:pubmed
pubmed-article:14624657pubmed:languagespalld:pubmed
pubmed-article:14624657pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14624657pubmed:citationSubsetIMlld:pubmed
pubmed-article:14624657pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14624657pubmed:statusMEDLINElld:pubmed
pubmed-article:14624657pubmed:monthNovlld:pubmed
pubmed-article:14624657pubmed:issn0212-7199lld:pubmed
pubmed-article:14624657pubmed:authorpubmed-author:RocaBBlld:pubmed
pubmed-article:14624657pubmed:issnTypePrintlld:pubmed
pubmed-article:14624657pubmed:volume20lld:pubmed
pubmed-article:14624657pubmed:ownerNLMlld:pubmed
pubmed-article:14624657pubmed:authorsCompleteYlld:pubmed
pubmed-article:14624657pubmed:pagination585-93lld:pubmed
pubmed-article:14624657pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:14624657pubmed:meshHeadingpubmed-meshheading:14624657...lld:pubmed
pubmed-article:14624657pubmed:meshHeadingpubmed-meshheading:14624657...lld:pubmed
pubmed-article:14624657pubmed:meshHeadingpubmed-meshheading:14624657...lld:pubmed
pubmed-article:14624657pubmed:meshHeadingpubmed-meshheading:14624657...lld:pubmed
pubmed-article:14624657pubmed:meshHeadingpubmed-meshheading:14624657...lld:pubmed
pubmed-article:14624657pubmed:meshHeadingpubmed-meshheading:14624657...lld:pubmed
pubmed-article:14624657pubmed:meshHeadingpubmed-meshheading:14624657...lld:pubmed
pubmed-article:14624657pubmed:meshHeadingpubmed-meshheading:14624657...lld:pubmed
pubmed-article:14624657pubmed:meshHeadingpubmed-meshheading:14624657...lld:pubmed
pubmed-article:14624657pubmed:year2003lld:pubmed
pubmed-article:14624657pubmed:articleTitle[Metabolic disorders associated with HIV and antiretroviral therapy].lld:pubmed
pubmed-article:14624657pubmed:affiliationUnidad de Enfermadades Infecciosas, Hospital General, Castellón. brocav@meditex.eslld:pubmed
pubmed-article:14624657pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:14624657pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:14624657pubmed:publicationTypeReviewlld:pubmed